skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

Frontiers in oncology, 2023-12, Vol.13, p.1337635-1337635 [Peer Reviewed Journal]

Copyright © 2023 Frontiers Editorial Office. ;Copyright © 2023 Frontiers Editorial Office 2023 Frontiers Editorial Office ;ISSN: 2234-943X ;EISSN: 2234-943X ;DOI: 10.3389/fonc.2023.1337635 ;PMID: 38130993

Full text available

Citations Cited by
  • Title:
    Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin
  • Subjects: Oncology
  • Is Part Of: Frontiers in oncology, 2023-12, Vol.13, p.1337635-1337635
  • Description: [This retracts the article DOI: 10.3389/fonc.2020.588533.].
  • Publisher: Switzerland: Frontiers Media S.A
  • Language: English
  • Identifier: ISSN: 2234-943X
    EISSN: 2234-943X
    DOI: 10.3389/fonc.2023.1337635
    PMID: 38130993
  • Source: PubMed Central (Open access)
    DOAJ Directory of Open Access Journals
    Geneva Foundation Free Medical Journals at publisher websites
    Alma/SFX Local Collection
    ROAD: Directory of Open Access Scholarly Resources

Searching Remote Databases, Please Wait